The response deadline has passed. Review the details for future reference or to track similar opportunities.
The Department of Defense is seeking information for the procurement of a Vela Diagnostics sequencing system for HIV-1 genotype testing for the Walter Reed Army Institute of Research. The requirement includes all necessary sub-system components, maintenance, repair, and operational supplies and consumables.
Provision of a brand-name Vela Diagnostics sequencing system for HIV-1 genotype testing, including all components, maintenance, and consumables.
for Information (RFI) /Sources Sought (SS) Notice RFI Number: HT9426-26-RFI-5892 Requiring Activity Name: The Walter Reed Army Institute of Research (WRAIR)
Contracting Office: Defense Health Agency Contacting Activity (DHACA) Subject: WRAIR has a need for a Vela Diagnostics sequencing system (Brand name only) for HIV-1 genotype testing to include all required sub-system components, maintenance and repair, and operational supplies and consumable products.
Place of Performance or Delivery: Silver Spring, MD 20910 General Information: In accordance with Revolutionary FAR Overhaul (RFO) 15.101; Exchange with industry before receipt of proposals, this Sources Sought is for information and planning purposes only and at this time shall not be construed as a solicitation or as an obligation or commitment on the part of the Government nor will the Government pay for information solicited. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are advised that the United States Government will not pay for any information or administrative costs incurred in response to this RFI. All costs associated with responding to this RFI/SS will be solely at the interested responder’s expense. Not responding to this RFI/SS does not preclude participation in any future Request for Proposal, if any is issued. No evaluation letters and/or results will be issued to Responders responding to this RFI/SS. This Sources Sought Notice is a Market Research tool used to determine the availability and adequacy of potential sources, prior to determining the method of acquisition and issuance of a solicitation. The NAICS code for this requirement is: 325413 - In-Vitro Diagnostic Substance Manufacturing DISCLAIMER: This Request for Information (RFI)/Sources Sought (SS) Notice is NOT a Request for Proposals (RFP) or a Request for Quotations (RFQ). This RFI is issued solely for market research information and planning purposes only and does not constitute a solicitation. Responses to the RFI will not be returned. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. No contract will be awarded from this announcement. No reimbursement will be made of any costs to provide information in response to this announcement or any follow-up information requests; responders are solely responsible for all expenses associated with responding to this RFI. Availability of any formal solicitation will be announced under a separate announcement. All information received in response to this RFI will be treated as confidential business information. Submitters should properly mark their responses if the information is confidential. All information received in response to this RFI that is marked Proprietary, will be handled accordingly. At this time,
questions concerning the composition and
requirements for future solicitation will not be entertained. RFI Response and due date: 11:00am EST on
09 July 2026 Instructions to Responders: Responses from all capable and qualified sources are encouraged to respond to this request. Review the attached Minimum Essential Characteristics (MECs) . Respondents should address how they best can fulfil the
Get matched to contracts like this daily
Free AI-powered contract matching for your business.